Entrar/Registro  
HOME SPANISH
 
Revista de Hematología
   
MENU

Contents by Year, Volume and Issue

Table of Contents

General Information

Instructions for Authors

Message to Editor

Editorial Board






>Journals >Revista de Hematología >Year 2012, Issue 2


Ron GCS
Association Between Congenital Neutropenia and Strabismus and Nystagmus: A New X Chromosome-Linked Syndrome. Study of a Family
Rev Hematol Mex 2012; 13 (2)

Language: Español
References: 21
Page: 58-64
PDF: 151.59 Kb.


Full text




ABSTRACT

Background: Congenital neutropenia is a primary immunodeficiency whose mode of inheritance is heterogeneous, affected genes can be located in the autosomes or in the gonosomes, therefore its prevalence throughout generations covers the entire spectrum of Mendelian inheritances as well as of chromosome X linked inheritances. Congenital neutropenia is characterized by chronic neutropenia due to a congenital constitutional defect. In the past decade the molecular bases of several entities that facilitate a classification have been discovered.
Objective: To report the case of a woman with Congenital neutropenia, with maturation halt in the myelocytes to metamyelocytes phase: partial albinism, nystagmus, convergent strabismus, with a genetic history linked to the X chromosome.
Material and Methods: A 4 years old girl was identified with Congenital neutropenia, convergent strabismus, horizontal nystagmus and partial albinism; she was followed up for 17 years until she died of respiratory failure secondary to pulmonary fibrosis. During this period of time we expected a similar syndrome description to arise, however no other syndrome appeared. Nevertheless, three family members appeared with the same characteristics of the syndrome and we did the investigation through a family tree, we found it was linked to the X chromosome and lethal in males affected.
Results: The patient had repeated upper and lower respiratory tract infections at a young age as well as otitis, gingivitis and skin infections. It was characterized by severe neutropenia with normalization of neutrophils with the application of G-CSF. The patient died at 22, she developed pulmonary fibrosis one year earlier. In her genetic history three more women were identified with the same syndrome: two first cousins, one of them died at age 10 from an intra-abdominal infection, the other one survives but suffers from repeated infections and moderate to severe neutropenia; the other one is 2 years old, she is first cousin of the patient that still survives, with the same characteristics of the syndrome. Comparisons were carried out with the different syndromes known that could be considered as one more of the ones already described; however, not all phenotype, genetic or histological characteristics were linked. Therefore, it is important to investigate a genetic molecular defect to include it in the current classification of congenital neutropenias.
Conclusions: This is a new syndrome not described yet in medical literature; it is characterized by congenital neutropenia with a halting of granulocyte maturity in the myelocyte to metamyelocyte phase, partial albinism, convergent strabismus, nystagmus and probably linked to the X chromosome.


Key words: Congenital neutropenia, albinism, pulmonary fibrosis.


REFERENCIAS

  1. Dale DC, Cottle TE, Fier CJ, Bolyard AA, et al. Severe chronic neutropenia: treatment and follow-ap of patients in the Severe Chronic Neutropenia International Registry. Am J Hematol 2003;72:82-93.

  2. Donadieu J, Leblanc T, Bader MB, Barkaoui M, Fenneteau O, et al. Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group. Hematologica 2005;90:45-53.

  3. Notarangelo LD, Fisher A, Geha RS, Casanova JL, Chapel H, et al. Primary immunodeficiencies: 2009 update. J Allergy Clin Immunol 2009;124:1161-1178.

  4. Zeidler C, Germeshausen M, Klein C, Welte K. Clinical implications of ELA-2, HAX1 and G-CSF-receptor (CSF3R) mutations in severe congenital neutropenia. Br J Haematol 2009;144:459-467.

  5. Klein C. Congenital neutropenia. Hematology Am Soc Hematl Educ Program 2009;344-50.

  6. Donadieu J, Fenneteau O, Beaupain B, Nahlaoui N, Chantelot CB. Congenital neutropenia: diagnosis, molecular bases and patient management. Orphanet J of Rare Diseases, review 2011;6:26.

  7. Monroe BL, Weinberg AG, Rosenfeld CR, Browne R. The neonatal blood count in the health and disease I. Reference values for neutrophillic cells. J Pediatr 1979;95:89-98.

  8. Schelonka RL, Yoder BA, Jardins SE, Hall RB, Butler J. Peripheral leukocyte count and leukocyte indexes in healthy newborn term infants. J Pediatr 1994;125:603-606.

  9. Schelonka RL, Yoder BA, Hall RB, Trippett TM, Louder DS, et al. Differentiation of segmented and band neutrophils during the early newborn period. J Pediatr 1995;127:298-300.

  10. Baehner RL, Johnston RB Jr. Monocyte function in children with neutropenia and chronic infections. Blood 1972;40:31-41.

  11. Kostmann R. Infantile genetic agranulocytosis; agranulocytosis infantilis hereditaria. Acta Paediatr Suppl 1956;45:1-78.

  12. Carlsson G, van´t HI, Melin M, Entesarian M, Laurencikas E, et al. Central nervous system involvement in severe congenital neutropenia: neurological and neuropsychological abnormalities associated with specific HAX1 mutations. J Inter Med 2008;264:368-400.

  13. Hermansky F, Pudlak P. Albinism Associated with Hemorrhagic Diathesis and Unusual Pigmented Reticular Cells in the Bone Marrow: Report of two Cases with Histochemical Studies. Blood 1959;14:162-169.

  14. Bohn G, Allroth A, Brandes G, Thiel G, Glocker E, et al. A novel human primary immunodeficiency syndrome caused by deficiency of the endosomal adaptor protein p14. Nat Med 2007;13:38-45.

  15. Ward DM, Shiflett SL, Kaplan J. Chédiak-Higashi syndrome: A clinical and molecular view of rare lysosomal storage disorder. Curr Mol Med 2002;2:469.

  16. Bellanne-Chantelot C, Clauin S, Leblanc T, Cassinat B, Cassinat B, et al. Mutations in the ELA2 gene correlate with more severe expression of neutropenia: a study of 81 patients from the French Neutropenia Register. Blood 2004;103:4119-4125.

  17. Ancliff PJ, Blundell MP, Cory GO, Calle Y, Worth A, et al. Two novel activating mutations in the Wiskott-Aldrich syndrome protein result in congenital neutropenia. Blood 2006;108:2182-2189.

  18. Boztug K, Appaswamy G, Ashikov A, Schaffer A, Salzer U, et al. A syndrome with congenital neutropenia and mutations in G6PC3. N Eng J Med 2009;360:32-43.

  19. Druhan LJ, Ai J, Massullo P, Kindwall-Keller T, Ranalli MA, et al. Novel mechanism of G-CSF refractoriness in patients with severe congenital neutropenia. Blood 2005;105:584-591.

  20. Xia J, Bolyard AA, Rodger E, Stein S, Aprikyan AA, et al. Prevalence of mutations in ELANE, GFI1, HAX1, SBDS, WAS and G6PC3 in patients with severe congenital neutropenia. Br J Haematol 2009;147:535-542.

  21. Barth PG, Wanders RJ, Vreken P, Janssen EA, Lam J, Baas F. X-linked cardioskeletal myopathy and neutropenia (Barth syndrome) (MIM 302060). J Inherit Met Dis 1999;22:555-567.






>Journals >Revista de Hematología >Year 2012, Issue 2
 

· Journal Index 
· Links 






       
Copyright 2019